Daré, a leader in women’s health innovation has recently announced completion of patient recruitment in its Phase 1 clinical trial of DARE-HRT1 being conducted through its wholly owned subsidiary in Australia. DARE-HRT1 is a novel intravaginal ring (IVR) designed to deliver bio-identical 17β-estradiol and bio-identical progesterone continuously over a 28-day period. It is being developed for the treatment of vasomotor symptoms (VMS)…
Gynesonics, a women’s healthcare company focused on the development of minimally invasive solutions for symptomatic uterine fibroids, announced today that medical device executive Susan Stimson has been appointed as an independent member to the company’s Board of Directors. Ms. Stimson joins the Gynesonics’ Board with more than 25 years of experience in the development and commercialization of high-impact medical devices. She currently…
A couple of years ago Lia’s story began with a vision: To create a better experience for women during one of the most emotional moments of their lives. Last week, a couple of years after founding the company and $2.6M in raised capital, Lia has now announced the launch of the world’s first flushable and biodegradable pregnancy test. “After six years of…
Celmatix, the leading women’s health biotech focused uniquely on ovarian biology, today announced that Dr. Stephen Palmer has joined its Scientific Advisory Board. Along with other board members, Dr. Palmer will play an instrumental role in supporting the continued success of Celmatix’s lead RSTK agonist program as it progresses through preclinical development, initiation of a follow-on RSTK antagonist program, and continued pipeline…
Evofem has recently announced publication of the pivotal manuscript from the AMPREVENCE clinical trial in the highly respected American Journal of Obstetrics and Gynecology (AJOG). This double-blinded, placebo-controlled, multicenter study of EVO100 met its primary and secondary efficacy endpoints with statistically significant reductions in the risk of chlamydia and gonorrhea infections in women at high risk of infection. “We believe publication of this important manuscript in such a prestigious…
With the ultimate goal of increasing pregnancy rates in infertile couples by up to 50%, Fertility Focus, the company behind OvuSense, has pioneered a new approach to infertility diagnosis and treatment for many years. After recently expanding the range of fertility monitoring products that work with the OvuSense app, the company has now announced a rebrand. To help distinguish between the fertility…
New York based Menopause startup Elektra Health has recently rebranded and as part of this effort launched a “21st Century Guide to Menopause”. The goal of this comprehensive roadmap is to equip women with the knowledge they need to naviagate menopause with “strength, grace, and a dash of taboo-smashing boldness. “We’re creating a movement to reimagine menopause as the beginning of a…
Family health and benefits startup Cleo, which works with companies like Salesforce and Pinterest, has recently announced a series of features and initiatives that focus on diversity, equity, and inclusion, aimed at improving health outcomes for all parents and providing inclusive resources for BIPOC and LGBTQ individuals. “Historically, healthcare has had a very broken relationship with BIPOC and other minoritized groups, who…
